New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareThymalin vs Chonluten

Thymalin vs Chonluten

Side-by-side comparison of key properties, dosing, and research.

Immune SupportAnti-Aging & Longevity
Thymalin
Anti-Aging & Longevity
Chonluten
Summary
Thymalin is a polypeptide complex isolated from calf thymus glands (developed by the Russian Gerontology Institute), shown to restore immune function, extend lifespan, and reverse thymic involution. Clinical studies demonstrate improved immune parameters and up to 40% reduction in mortality in elderly patients.
Chonluten is a tripeptide bioregulator (Glu-Asp-Leu) developed by Professor Vladimir Khavinson, tissue-specific to the bronchi and lungs. While related to Bronchogen (a tetrapeptide), Chonluten is a shorter tripeptide sequence. It supports bronchial mucosal cell function, promotes respiratory epithelial regeneration, and is used in protocols for COPD, chronic bronchitis, and pulmonary anti-aging.
Half-Life
Not well characterized as a complex extract; individual peptides have varying kinetics
Short (minutes for the peptide); sustained gene-regulatory effects
Admin Route
SubQ, IM
SubQ, Oral
Research
Typical Dose
10 mg IM or SC daily
10 mg per day
Frequency
Once daily
Daily for 10–30 days
Key Benefits
  • Restores thymic function and T-cell immunity
  • Extends healthy lifespan (documented in long-term studies)
  • Reduces infectious disease incidence in elderly
  • Normalizes immune parameters in immunodeficiency
  • Anti-tumor immune surveillance
  • Improves vaccine response in elderly
  • Reduces cardiovascular mortality (40% in landmark Russian study)
  • Normalizes neuroendocrine function
  • Supports bronchial mucosal regeneration and repair
  • May improve mucociliary clearance in chronic respiratory conditions
  • Anti-inflammatory effects on bronchial epithelium
  • Pulmonary anti-aging and tissue preservation
  • Supports lung function in COPD and chronic bronchitis
  • Well tolerated in combination with other Khavinson bioregulators
  • Short tripeptide with efficient cellular penetration
Side Effects
  • Very well tolerated in decades of Russian clinical use
  • Mild injection site reactions
  • Rare: mild allergic reaction (natural extract)
  • Transient flu-like symptoms on initiation (immune activation)
  • Generally well tolerated
  • Mild injection site reactions possible
  • No significant adverse pulmonary events reported
Stacks With